These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16095152)

  • 1. [Soluble tumor-necrosis-factor-alpha receptor type-1 as a marker of activity of psoriasis vulgaris and effects of its treatment].
    Serwin AB; Sokołowska M; Chodynicka B
    Przegl Lek; 2005; 62(2):95-7. PubMed ID: 16095152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selenium supplementation, soluble tumor necrosis factor-alpha receptor type 1, and C-reactive protein during psoriasis therapy with narrowband ultraviolet B.
    Serwin AB; Wasowicz W; Chodynicka B
    Nutrition; 2006 Sep; 22(9):860-4. PubMed ID: 16829029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble tumor necrosis factor alpha receptor type 1 in psoriasis patients treated with narrowband ultraviolet B.
    Serwin AB; Sokolowska M; Chodynicka B
    Photodermatol Photoimmunol Photomed; 2005 Aug; 21(4):210-1. PubMed ID: 15998370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour necrosis factor alpha (TNF-alpha)-converting enzyme (TACE) and soluble TNF-alpha receptor type 1 in psoriasis patients treated with narrowband ultraviolet B.
    Serwin AB; Sokolowska M; Chodynicka B
    Photodermatol Photoimmunol Photomed; 2007 Aug; 23(4):130-4. PubMed ID: 17598866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble tumor necrosis factor-alpha receptor type 1 during selenium supplementation in psoriasis patients.
    Serwin AB; Mysliwiec H; Hukalowicz K; Porebski P; Borawska M; Chodynicka B
    Nutrition; 2003 Oct; 19(10):847-50. PubMed ID: 14559319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble tumour necrosis factor-alpha receptor type 1 as a biomarker of response to phototherapy in patients with psoriasis.
    Serwin AB; Chodynicka B
    Biomarkers; 2007; 12(6):599-607. PubMed ID: 17852084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
    Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
    Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of high-volume hemofiltration on serum levels of tumor necrosis factor and its receptors in patients with multiple organ dysfunction syndromes].
    Zhang J; Tao LJ; Ning JP; Xu H; Ai YH; Zhao SP
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Feb; 16(2):81-4. PubMed ID: 14764220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma.
    Goto N; Tsurumi H; Takemura M; Hara T; Sawada M; Kasahara S; Kanemura N; Yamada T; Shimizu M; Takahashi T; Tomita E; Seishima M; Takami T; Moriwaki H
    Eur J Haematol; 2006 Sep; 77(3):217-25. PubMed ID: 16856931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha-converting enzyme as a potential mediator of the influence of smoking on the response to treatment with narrowband ultraviolet B in psoriasis patients.
    Serwin AB; Sokolowska M; Chodynicka B
    Photodermatol Photoimmunol Photomed; 2010 Feb; 26(1):36-40. PubMed ID: 20070837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of psoriasis therapy on VEGF and its soluble receptors serum concentrations.
    Flisiak I; Zaniewski P; Rogalska-Taranta M; Chodynicka B
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):302-7. PubMed ID: 21418334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of etanercept on urine neopterin levels in patients with psoriasis in a controlled, open-label study.
    Koc E; Tunca M; Akgul EO; Akar A; Kurt Y; Kurumlu Z; Erbil K; Kilic S
    J Dermatol; 2009 Apr; 36(4):191-6. PubMed ID: 19348656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy.
    Markham T; Mullan R; Golden-Mason L; Rogers S; Bresnihan B; Fitzgerald O; Fearon U; Veale DJ
    J Am Acad Dermatol; 2006 Jun; 54(6):1003-12. PubMed ID: 16713454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on the T lymphocytes early activation and soluble tumor necrosis factor receptor in patients with aplastic anemia].
    Shen R; Xu CG; Li LZ; Zhang T; Qin XM; Li J; Zhao CL
    Zhonghua Xue Ye Xue Za Zhi; 2004 Apr; 25(4):209-12. PubMed ID: 15182557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of the pro-inflammatory cytokine interleukin-12 and the anti-inflammatory cytokine interleukin-10 in patients with psoriasis treated by the Goeckerman regimen.
    Borska L; Andrys C; Krejsek J; Hamakova K; Kremlacek J; Ettler K; Fiala Z
    Int J Dermatol; 2008 Aug; 47(8):800-5. PubMed ID: 18717859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated soluble tumor necrosis factor receptor 75 concentrations identify patients with liver cirrhosis at risk of death.
    Grünhage F; Rezori B; Neef M; Lammert F; Sauerbruch T; Spengler U; Reichel C
    Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1255-62. PubMed ID: 18995216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of lymphocyte populations in psoriatic plaques following inhibition of tumor necrosis factor alpha with etanercept].
    Mahiques L; Pitarch G; Sánchez-Carazo JL; Pérez-Ferriols A; Soriano CJ; Alegre V
    Actas Dermosifiliogr; 2007 Oct; 98(8):539-44. PubMed ID: 17919428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of psoriasis activity on VEGF and its soluble receptors concentrations in serum and plaque scales.
    Flisiak I; Zaniewski P; Rogalska M; Myśliwiec H; Jaroszewicz J; Chodynicka B
    Cytokine; 2010 Dec; 52(3):225-9. PubMed ID: 20980160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour necrosis factor (TNF-alpha) alpha converting enzyme and soluble TNF-alpha receptor type 1 in psoriasis patients in relation to the chronic alcohol consumption.
    Serwin AB; Sokolowska M; Dylejko E; Chodynicka B
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):712-7. PubMed ID: 18312327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.